TX-MOUSER-ELECTRONICS
Mouser Electronics , Inc., the New Product Introduction (NPI) leader™ empowering innovation, is excited to partner with the DRAGON / PENSKE AUTOSPORT team for the ABB Formula E FIA World Championship series’ eighth season, which kicks off with double-header races at Diriyah E-Prix on January 28 and 29. The fourth consecutive season-opener at Diriyah gives fans two exciting night races just outside Saudi Arabia’s capital of Riyadh.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220124005567/en/
Mouser is partnering with the DRAGON / PENSKE AUTOSPORT team throughout the 2021–22 ABB FIA Formula E World Championship racing season, in collaboration with TTI, Inc . and valued manufacturers Molex and KYOCERA AVX . This is the eighth-straight year that Mouser and Molex have sponsored Formula E racing.
Driver Sérgio Sette Câmara returns to the team to helm the No. 7 Penske EV-5 car, while Formula 1 reserve driver Antonio Giovinazzi joins the team to take the wheel of the No. 6 car. The new season serves up 16 races, including stops in Jakarta, Vancouver, and Seoul, plus increased car power and new race qualifying formats.
“Mouser is thrilled to team up with Molex, TTI and KYOCERA AVX to partner with DRAGON / PENSKE AUTOSPORT for the eighth year in a row,” said Todd McAtee, Vice President, Americas Business Development for Mouser Electronics. “Formula E’s focus on developing and incorporating the latest in electric vehicle technology resonates with Mouser, our customers, and our fans and followers. We wish Sette Câmara, Giovinazzi, and the team the best this season!”
"TTI is pleased to team up with Mouser in supporting this exciting sport and its spotlight on sustainable automotive technologies of the future,” said Mike Morton, TTI Chief Executive Officer.
“This new chapter of Formula E promises to continue the evolution of this thrilling sport and serves as a powerful showcase for its electric future,” said Fred Bell, Vice President of Global Distribution for Molex. “Mouser and Molex have been proud supporters since the inception of Formula E, and we wish the DRAGON / PENSKE AUTOSPORT team a safe and successful season.”
“We’re delighted to collaborate with Mouser, Molex, and TTI in our partnership with the DRAGON / PENSKE AUTOSPORT Formula E racing team for another exciting season,” said Alex Schenkel, KYOCERA AVX’s Senior Vice President of Global Sales.
The Formula E series features cars that are powered solely by electricity and represent a vision for the future of the motor sports industry, serving as a framework for research and development around zero-emission motoring. The Gen2 cars offer a huge step forward in electric vehicle racing technology, with maximum power of 250 kW and speeds up to 280 km/h. Racing is all about speed and endurance, and racing partnerships are an innovative way for Mouser to communicate its performance-driven business model and promote the newest technologies from its manufacturer partners.
Fans can cast a vote for Sette Câmara and Giovinazzi in FANBOOST , which allows fans to play an active role in influencing the outcome of the race. FANBOOST gives fans the opportunity to vote for their favorite driver and award them an extra boost of power during the race. The five drivers with the most FANBOOST votes are awarded a significant burst of power, which they can deploy in a 5-second window during the second half of the race. FANBOOST voting for the Diriyah E-Prix opens January 25 and is available up to 15 minutes into the race.
To learn more, visit https://www.mouser.com/formula-e/ .
For more Mouser news, visit https://www.mouser.com/newsroom/ .
As a global authorized distributor, Mouser offers the world’s widest selection of the newest semiconductors and electronic components — in stock and ready to ship™. Mouser’s customers can expect 100% certified, genuine products that are fully traceable from each of its manufacturer partners. To help speed customers’ designs, Mouser’s website hosts an extensive library of technical resources, including a Technical Resource Center , along with product data sheets, supplier-specific reference designs, application notes, technical design information, engineering tools and other helpful information.
Engineers can stay abreast of today’s exciting product, technology and application news through Mouser’s complimentary e-newsletter. Mouser’s email news and reference subscriptions are customizable to the unique and changing project needs of customers and subscribers. No other distributor gives engineers this much customization and control over the information they receive. Learn about emerging technologies, product trends and more by signing up today at https://sub.info.mouser.com/subscriber .
About Mouser Electronics
Mouser Electronics, a Berkshire Hathaway company, is an authorized semiconductor and electronic component distributor focused on New Product Introductions from its leading manufacturer partners. Serving the global electronic design engineer and buyer community, the global distributor's website, mouser.com, is available in multiple languages and currencies and features more than 5 million products from over 1,200 manufacturer brands. Mouser offers 27 support locations worldwide to provide best-in-class customer service in local language, currency and time zone. The distributor ships to over 630,000 customers in 223 countries/territories from its 1 million-square-foot, state-of-the-art distribution facilities in the Dallas, Texas, metro area. For more information, visit https://www.mouser.com/ .
Trademarks
Mouser and Mouser Electronics are registered trademarks of Mouser Electronics, Inc. All other products, logos, and company names mentioned herein may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005567/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 08:00:00 CET | Press release
After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new IDEAL Japan initiativeThe “Innovation Debiopharm Academia Life Science” (IDEAL) program is designed to financially and scientifically support academic research with the goal of accelerating the translation of innovation into novel therapies for patientsThe first IDEAL Japan agreement was signed with the National Cancer Center Japan Research Institute Laboratory of Genome Stability Maintenance to advance research in early-stage colon cancer Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approa
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release
Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 04:35:00 CET | Press release
Powering the Next Wave of MSME Growth with Digital Platforms in Emerging MarketsThere was a threefold year-on-year increase in eligible customers reached through partners using Bettr's credit tech solutions by the end of October 2025.The solution features an AI-driven, alternative-data-powered credit engine that can help partner platforms to cut credit policy deployment from weeks to minutes.Partnership with Dock, a leading Brazilian payments and banking technology provider, will expand the deployment of Bettr’s credit tech solutions. Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through
Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 04:00:00 CET | Press release
Ant International has been a participant in the Ensemble Sandbox since 2024 Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in r
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg18.11.2025 03:51:00 CET | Press release
Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in EuropeOmlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS).The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal polyps (CRSwNP). “The additional strength of Omlyclo™ 300mg can significantly decrease the frequency of injections, and reduce injection burden and discomfort, without compromising efficacy and safety,” said Nam Lee, Vice President of Global Medical Affairs at Celltrion. “These
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom